Rankings
▼
Calendar
BDTX Q1 2022 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
BDTX
Black Diamond Therapeutics, Inc.
$126M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$26M
Net Income
-$26M
EPS (Diluted)
$-0.70
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$29M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$219M
Total Liabilities
$47M
Stockholders' Equity
$173M
Cash & Equivalents
$54M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$26M
-$31M
+16.4%
Net Income
-$26M
-$30M
+15.8%
← FY 2022
All Quarters
Q2 2022 →